Skip to main content
Premium Trial:

Request an Annual Quote

Ambion: May 20, 2005


Ambion has recently introduced the TRI reagent.

According to the company, the reagent is used for the isolation of total RNA, or the simultaneous isolation of RNA, DNA, and protein, from a variety of biological samples.

The reagent "combines phenol and guanidine thiocyanate in a monophase solution to facilitate the immediate inhibition of RNase activity," Ambion said. "Biological samples are homogenized or lysed in TRI Reagent, [and] the subsequent addition of bromochloropropane or chloroform results in the separation of the homogenate into aqueous and organic phases.

"RNA partitions to the aqueous phase, DNA to the interphase, and proteins to the organic phase," the company added. "The RNA can then be precipitated from the aqueous phase with the addition of isopropanol. The entire protocol can be completed in approximately 1 hour."

Additional details about the reagent can be found at

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.